Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
4(44%)
Results Posted
33%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_3
1
11%
Ph phase_4
1
11%
Ph phase_2
2
22%
Ph not_applicable
5
56%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Recruiting4
Completed3
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (22.2%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A5 (55.6%)

Trials by Status

terminated111%
completed333%
recruiting444%
unknown111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9